Brainfarma Industria Química E Farmacêutica S/a
Clinical trials sponsored by Brainfarma Industria Química E Farmacêutica S/a, explained in plain language.
Brazilian pharmaceutical company producing generic and branded medicines.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
Could a Once-Daily pill ease nerve pain just as well as the standard Twice-Daily dose?
Symptom relief Recruiting nowThis phase 3 trial tests whether an extended-release (once-daily) form of pregabalin works as well as the standard immediate-release (twice-daily) form for relieving nerve pain caused by diabetic peripheral neuropathy or postherpetic neuralgia. About 348 adults aged 18 to 75 with…
Phase: PHASE3 • Sponsor: Brainfarma Industria Química e Farmacêutica S/A • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
New Triple-Action pill takes on cold and flu symptoms
Symptom relief Recruiting nowThis study tests a new pill containing three ingredients (dipyrone, caffeine, and chlorpheniramine) to see if it works as well as a standard cold medicine for relieving stuffy nose and other cold and flu symptoms. About 620 adults with early cold or flu symptoms will take either …
Phase: PHASE3 • Sponsor: Brainfarma Industria Química e Farmacêutica S/A • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC